Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,933 | -1,713 | -1,592 | -190 | -1,372 |
| Depreciation Amortization | 109 | 70 | 35 | 170 | 132 |
| Other Working Capital | 3,842 | 4,388 | 972 | -50 | -113 |
| Other Operating Activity | 356 | 325 | 585 | 260 | 274 |
| Operating Cash Flow | $2,375 | $3,071 | $1 | $190 | $-1,080 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -227 | -98 | -16 | -30 | -24 |
| Investing Cash Flow | $-227 | $-98 | $-16 | $-30 | $-24 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26 | 15 | 3 | N/A | 1,612 |
| Other Financing Activity | 0 | 0 | 0 | 1,640 | -800 |
| Financing Cash Flow | $26 | $15 | $3 | $1,640 | $812 |
| Beginning Cash Position | 2,705 | 2,705 | 2,705 | 900 | 909 |
| End Cash Position | 4,879 | 5,693 | 2,693 | 2,700 | 617 |
| Net Cash Flow | $2,174 | $2,988 | $-12 | $1,790 | $-292 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,375 | 3,071 | 1 | 190 | -1,080 |
| Capital Expenditure | -227 | -98 | -16 | N/A | -24 |
| Free Cash Flow | 2,148 | 2,973 | -15 | 190 | -1,104 |